WNV NS3 anticorps (N-Term)
-
- Antigène
- WNV NS3 (West Nile Virus NS3 (WNV NS3))
- Épitope
- N-Term
- Reactivité
- West Nile Virus (WNV)
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Application
- Immunocytochemistry (ICC), Immunofluorescence (IF), Western Blotting (WB)
- Réactivité croisée
- West Nile Virus (WNV)
- Purification
- Purified by antigen-affinity chromatography.
- Immunogène
- Recombinant protein encompassing a sequence within the N-terminus region of West Nile virus NS3 protein (West Nile virus (strain NY99-IC)). The exact sequence is proprietary.
- Isotype
- IgG
-
- Indications d'application
- WB: 1:500-1:3000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
- Commentaires
-
Positive Control: WNV-infected vero cell , WNV NS3-transfected 293T cells , WNV-infected 293T
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.94 mg/mL
- Buffer
- 1XPBS ( pH 7), 20 % Glycerol, 0.025 % ProClin 300
- Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
- Antigène
- WNV NS3 (West Nile Virus NS3 (WNV NS3))
- Autre désignation
- West Nile Virus NS3
- Sujet
- West Nile virus Non-structural protein 3 , West Nile virus NS3 , WNV Non-structural protein 3 , WNV NS3
-